RxSight Light Adjustable Lens (RxLAL) 60005-3060Recalls & reported problems
Rxsight, Inc. · LAL, Sterile, Packaged, 6.0 Diopter · Class 3 · Implant
All models of RxSight Light Adjustable Lens (RxLAL) (62)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00818806020913), received between Jun 1, 2023 and Jun 3, 2025 — classified as 3 injuries.
The most frequently reported specific device problem is “Optical Decentration” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Optical Decentration1
Patient problems
- Unspecified Eye / Vision Problem2
- Blurred Vision1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJun 3, 2025Optical Decentration; Optical Decentration
A SITE REPORTED TO RXSIGHT THAT A PATIENT'S LIGHT ADJUSTABLE LENS (LAL, SN (B)(6), +6.0D) WAS EXPLANTED FROM THE EYE DUE TO LENS DECENTRATION SECONDARY TO POSSIBLE ZONULAR DEHISCENCE OR A KINKED HAPTIC DURING DELIVERY OF THE LAL WHICH WAS CAUSED BY PRIOR INCOMPLETE REMOVAL OF AN IMPLANTABLE COLLAMER LENS; A NEW LAL (SN (B)(6), +6.0D) WAS IMPLANTED AS A REPLACEMENT.
Patient problems: Unspecified Eye / Vision Problem
MAUDE report 22137773 ↗InjuryApr 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A SITE REPORTED TO RXSIGHT THAT A PATIENT'S LIGHT ADJUSTABLE LENS (LAL, SN (B)(6), +6.0D) THAT WAS INITIALLY PLACED AS A PIGGYBACK INTRAOCULAR LENS IN THE CAPSULAR BAG WAS EXPLANTED FROM THE RIGHT EYE DUE TO BLURRY VISION AND A NEW LAL (SN (B)(6), +8.0D) IMPLANTED AS A REPLACEMENT.
Patient problems: Blurred Vision
MAUDE report 21910600 ↗InjuryJun 1, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE SITE REPORTED THAT A LIGHT ADJUSTABLE LENS (LAL SN (B)(6)) WAS EXPLANTED ON (B)(6) 2023. RXSIGHT'S FIRST AWARENESS OF THIS EVENT WAS ON (B)(6) 2023.
Patient problems: Unspecified Eye / Vision Problem
MAUDE report 17043647 ↗
Other Light Adjustable Lens (Lal) And Light Delivery Device (Ldd) devices
- RxSight Light Adjustable Lens (RxLAL) 60005-3205Rxsight, Inc. · Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)50 reports
- RxSight Light Adjustable Lens (RxLAL) 60005-3200Rxsight, Inc. · Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)47 reports
- RxSight Light Adjustable Lens (RxLAL) 60005-3210Rxsight, Inc. · Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)39 reports
- RxSight Light Adjustable Lens (RxLAL) 60005-3190Rxsight, Inc. · Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)32 reports
- RxSight Light Adjustable Lens (RxLAL) 60005-3195Rxsight, Inc. · Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)31 reports
- Light Adjustable Lens (LAL) 60007-0200Rxsight, Inc. · Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)31 reports
- RxSight Light Adjustable Lens (RxLAL) 60005-3215Rxsight, Inc. · Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)30 reports
- RxSight Light Adjustable Lens (RxLAL) 60005-3185Rxsight, Inc. · Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)29 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page